Cargando…

Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout

BACKGROUND: The aim of this study is to develop and assess usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy (ULT) among gout patients in a clinical setting. METHODS: The content of the tool was based on the Integrated Change (I-Change) model. This model c...

Descripción completa

Detalles Bibliográficos
Autores principales: te Kampe, Ritch, Boonen, Annelies, Jansen, Tim L., Elling, Jan Mathis, Flendrie, Marcel, van Eijk-Hustings, Yvonne, Janssen, Matthijs, van Durme, Caroline, de Vries, Hein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991610/
https://www.ncbi.nlm.nih.gov/pubmed/35392890
http://dx.doi.org/10.1186/s12911-022-01833-6
_version_ 1784683604763213824
author te Kampe, Ritch
Boonen, Annelies
Jansen, Tim L.
Elling, Jan Mathis
Flendrie, Marcel
van Eijk-Hustings, Yvonne
Janssen, Matthijs
van Durme, Caroline
de Vries, Hein
author_facet te Kampe, Ritch
Boonen, Annelies
Jansen, Tim L.
Elling, Jan Mathis
Flendrie, Marcel
van Eijk-Hustings, Yvonne
Janssen, Matthijs
van Durme, Caroline
de Vries, Hein
author_sort te Kampe, Ritch
collection PubMed
description BACKGROUND: The aim of this study is to develop and assess usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy (ULT) among gout patients in a clinical setting. METHODS: The content of the tool was based on the Integrated Change (I-Change) model. This model combines various socio-cognitive theories and assumes behavioral change is a result of becoming aware of the necessity of change by integrating pre-motivational, motivational, and post-motivational factors. An expert group (five gout experts, three health services researchers, and one health behavior expert) was assembled that decided in three meetings on the tool’s specific content (assessments and personalized feedback) using information from preparatory qualitative studies and literature reviews. Usability was tested by a think aloud approach and validated usability questionnaires. RESULTS: The I-Change Gout tool contains three consecutive sessions comprising 80 questions, 66 tailored textual feedback messages, and 40 tailored animated videos. Navigation through the sessions was determined by the patients’ intention to adapt suboptimal ULT adherence. After the sessions, patients receive an overview of the personalized advices and plans to support ULT adherence. Usability testing among 20 gout patients that (ever) used ULT and seven healthcare professionals revealed an overall score for the tool of 8.4 ± 0.9 and 7.7 ± 1.0 (scale 1–10). Furthermore, participants reported a high intention to use and/or recommend the tool to others. Participants identified some issues for further improvement (e.g. redundant questions, technical issues, and text readability). If relevant, these were subsequently implemented in the I-Change Gout tool, to allow further testing among the following participants. CONCLUSION: This study provides initial support for the usability by patients and healthcare professionals of the I-Change Gout tool to support ULT adherence behavior. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01833-6.
format Online
Article
Text
id pubmed-8991610
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89916102022-04-09 Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout te Kampe, Ritch Boonen, Annelies Jansen, Tim L. Elling, Jan Mathis Flendrie, Marcel van Eijk-Hustings, Yvonne Janssen, Matthijs van Durme, Caroline de Vries, Hein BMC Med Inform Decis Mak Software BACKGROUND: The aim of this study is to develop and assess usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy (ULT) among gout patients in a clinical setting. METHODS: The content of the tool was based on the Integrated Change (I-Change) model. This model combines various socio-cognitive theories and assumes behavioral change is a result of becoming aware of the necessity of change by integrating pre-motivational, motivational, and post-motivational factors. An expert group (five gout experts, three health services researchers, and one health behavior expert) was assembled that decided in three meetings on the tool’s specific content (assessments and personalized feedback) using information from preparatory qualitative studies and literature reviews. Usability was tested by a think aloud approach and validated usability questionnaires. RESULTS: The I-Change Gout tool contains three consecutive sessions comprising 80 questions, 66 tailored textual feedback messages, and 40 tailored animated videos. Navigation through the sessions was determined by the patients’ intention to adapt suboptimal ULT adherence. After the sessions, patients receive an overview of the personalized advices and plans to support ULT adherence. Usability testing among 20 gout patients that (ever) used ULT and seven healthcare professionals revealed an overall score for the tool of 8.4 ± 0.9 and 7.7 ± 1.0 (scale 1–10). Furthermore, participants reported a high intention to use and/or recommend the tool to others. Participants identified some issues for further improvement (e.g. redundant questions, technical issues, and text readability). If relevant, these were subsequently implemented in the I-Change Gout tool, to allow further testing among the following participants. CONCLUSION: This study provides initial support for the usability by patients and healthcare professionals of the I-Change Gout tool to support ULT adherence behavior. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01833-6. BioMed Central 2022-04-07 /pmc/articles/PMC8991610/ /pubmed/35392890 http://dx.doi.org/10.1186/s12911-022-01833-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
te Kampe, Ritch
Boonen, Annelies
Jansen, Tim L.
Elling, Jan Mathis
Flendrie, Marcel
van Eijk-Hustings, Yvonne
Janssen, Matthijs
van Durme, Caroline
de Vries, Hein
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title_full Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title_fullStr Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title_full_unstemmed Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title_short Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
title_sort development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991610/
https://www.ncbi.nlm.nih.gov/pubmed/35392890
http://dx.doi.org/10.1186/s12911-022-01833-6
work_keys_str_mv AT tekamperitch developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT boonenannelies developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT jansentiml developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT ellingjanmathis developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT flendriemarcel developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT vaneijkhustingsyvonne developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT janssenmatthijs developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT vandurmecaroline developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout
AT devrieshein developmentandusabilityofawebbasedpatienttailoredtooltosupportadherencetourateloweringtherapyingout